Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biosedra is an independent French pharmaceutical laboratory specialized in the commercialization of niche hospital medicines. Founded in 2011, the company focuses on therapeutic areas such as oncology, hematology, and rare diseases, particularly in the context of hematopoietic stem cell transplantation. Biosedra operates primarily as a "laboratoire exploitant," managing the regulatory, medical, and commercial aspects of bringing essential treatments to the French market. Their portfolio consists of high-value injectable drugs, including alkylating agents used for conditioning regimens. By partnering with international manufacturers, Biosedra ensures the availability of critical therapies for specialized hospital departments. The company is headquartered in Paris and maintains a lean, expert-driven organizational structure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biosedra Laboratoires.